LLGL2 Activators
In the context of LLGL2 Activators, this group of chemicals can indirectly impact the function of LLGL2 by affecting cell polarity, cell proliferation, or the Hippo signaling pathway. Verteporfin and XMU-MP-1 are known to influence the Hippo signaling pathway, which LLGL2 proteins are known to interact with. Doxorubicin, Paclitaxel, LY294002, and Sodium orthovanadate can influence cell proliferation, a process that LLGL2 is involved in, thus potentially affecting its activity.
Y-27632, Blebbistatin, Cytochalasin D, Nocodazole, Jasplakinolide, and Forskolin can influence cell polarity, a fundamental aspect of LLGL2's function, thus potentially impacting its activity. These chemicals provide a means to explore the roles and regulation of LLGL2 in cell polarity and cell proliferation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verteporfin | 129497-78-5 | sc-475698 sc-475698A | 10 mg 100 mg | $347.00 $2710.00 | 5 | |
Verteporfin can influence the Hippo signaling pathway, potentially affecting LLGL2 activity indirectly. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin can influence cell proliferation, potentially affecting LLGL2 activity indirectly. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Paclitaxel can influence cell proliferation, potentially affecting LLGL2 activity indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor and can influence cell proliferation, potentially affecting LLGL2 activity indirectly. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 is a ROCK inhibitor and can influence cell polarity, potentially affecting LLGL2 activity indirectly. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $179.00 $307.00 $455.00 $924.00 $1689.00 | 7 | |
Blebbistatin inhibits non-muscle myosin II, which is involved in maintaining cell polarity, potentially affecting LLGL2 activity indirectly. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Cytochalasin D can influence cell polarity by disrupting the actin cytoskeleton, potentially affecting LLGL2 activity indirectly. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Nocodazole can influence cell polarity by disrupting the microtubule network, potentially affecting LLGL2 activity indirectly. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Jasplakinolide can influence cell polarity by stabilizing the actin cytoskeleton, potentially affecting LLGL2 activity indirectly. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin can influence cell polarity by increasing intracellular cAMP levels, potentially affecting LLGL2 activity indirectly. | ||||||